{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:51:33Z","timestamp":1778867493567,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In malaria endemic areas, schoolchildren usually have asymptomatic malaria infections and consequently remain untreated. Therefore, intermittent preventive treatment with sulfadoxine-pyrimethamine in schoolchildren would be a plausible strategy in malaria stable transmission areas to prevent anaemia and malnutrition. However, in contrast to infancy and pregnancy, antimalaria intermittent preventive treatment in children has been barely investigated. As the implementation of intermittent preventive treatment may be challenged by sulfadoxine-pyrimethamine resistance, sulfadoxine-pyrimethamine combined with piperaquine may be a better alternative than sulfadoxine-pyrimethamine monotherapy. A clinical trial is being conducted to assess the efficacy and safety of intermittent preventive treatments versus controls in Democratic Republic of Congo (DRCongo) schoolchildren and their impact on sulfadoxine-pyrimethamine resistance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/Design<\/jats:title>\n            <jats:p>A phase IIIb, randomised, controlled trial will enroll asymptomatic schoolchildren. For interventions, sulfadoxine-pyrimethamine is compared to sulfadoxine-pyrimethamine plus piperaquine and to a control group. The two treatments are given four-monthly from baseline for a year as a single dose for sulfadoxine-pyrimethamine and two doses at 24-hour intervals for piperaquine. All participants receive praziquantel and albendazole as mass-treatment for helminthiasis at enrolment. The primary endpoint is haemoglobin concentration change at 12 months follow-up. Secondary endpoints are malaria parasite load and malaria prevalence, at baseline and at month 12. Malaria and helminthiasis incidence will be monitored throughout the study. Statistical analysis will use multilevel modelling due to repeated measurements and clustering effect of participants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The very few studies on intermittent preventive treatment in schoolchildren in malaria stable transmission areas have contradictory results. This randomised controlled trial is unique in comparing efficacy and safety of a prophylactic combination therapy to monotherapy or a control group after 12 months follow-up. Resistance markers for sulfadoxine-pyrimethamine (including break through parasitaemias) will also be recorded. Its uniqueness lies also in the fact that we use piperaquine, a long acting antimalarial, in combination with sulfadoxine-pyrimethamine. Artemisinin derivatives have been excluded as it is part of the treatment policies in virtually all malaria endemic countries. Our findings may, therefore, contribute to the public health of youngsters who fail to thrive and grow due to multiple morbidities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01722539\" ext-link-type=\"uri\">NCT01722539<\/jats:ext-link>; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.pactr.org\/ATMWeb\/appmanager\/atm\/atmregistry?_nfpb=true&amp;_windowLabel=basicSearch_1_2&amp;basicSearch_1_2_actionOverride=%2Fpageflows%2Ftrial%2FbasicSearch%2FviewTrail&amp;basicSearch_1_2id=449\" ext-link-type=\"uri\">PACTR201211000449323<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1745-6215-14-311","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T17:27:28Z","timestamp":1380043648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"14","author":[{"given":"Joachim Yorokpa","family":"Doua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junior","family":"Matangila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lutumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Van geertruyden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,24]]},"reference":[{"key":"2439_CR1","first-page":"427","volume":"126","author":"A Kantele","year":"2010","unstructured":"Kantele A, Jokiranta S: Plasmodium knowlesi\u2013the fifth species causing human malaria. Duodecim. 2010, 126: 427-434.","journal-title":"Duodecim"},{"key":"2439_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","volume":"379","author":"CJ Murray","year":"2012","unstructured":"Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012, 379: 413-431. 10.1016\/S0140-6736(12)60034-8.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"2439_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2004.71.2_suppl.0700001","volume":"71","author":"JG Breman","year":"2004","unstructured":"Breman JG, Alilio MS, Mills A: Conquering the intolerable burden of malaria: what\u2019s new, what\u2019s needed: a summary. Am J Trop Med Hyg. 2004, 71 (Suppl 2): 1-15.","journal-title":"Am J Trop Med Hyg"},{"key":"2439_CR4","volume-title":"World Malaria Report","author":"World Heath Organisation","year":"2010","unstructured":"World Heath Organisation: World Malaria Report. 2010,http:\/\/www.who.int\/malaria\/world_malaria_report_2010\/worldmalariareport2010.pdf,"},{"key":"2439_CR5","volume-title":"Document de Strat\u00e9gie de la Croissance et de la Reduction de la Pauvret\u00e9 (DSCRP)","author":"R\u00e9publique D\u00e9mocratique du Congo Republique D\u00e9mocratique du Congo","year":"2010","unstructured":"R\u00e9publique D\u00e9mocratique du Congo Republique D\u00e9mocratique du Congo: Document de Strat\u00e9gie de la Croissance et de la Reduction de la Pauvret\u00e9 (DSCRP). 2010,http:\/\/www.cd.undp.org\/mediafile\/Note%20Sant%C3%A9.pdf,"},{"key":"2439_CR6","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1371\/journal.pntd.0000270","volume":"2","author":"PJ Hotez","year":"2008","unstructured":"Hotez PJ, Molyneux DH: Tropical anemia: one of Africa\u2019s great killers and a rationale for linking malaria and neglected tropical disease control to achieve a common goal. PLoS Negl Trop Dis. 2008, 2: e270-10.1371\/journal.pntd.0000270.","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 1","key":"2439_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0035-9203(99)90329-2","volume":"93","author":"T Smith","year":"1999","unstructured":"Smith T, Felger I, Tanner M, Beck HP: Premunition in plasmodium falciparum infection: insights from the epidemiology of multiple infections. Trans R Soc Trop Med Hyg. 1999, 93 (Suppl 1): 59-64.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2439_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.trstmh.2004.03.010","volume":"98","author":"L Henning","year":"2004","unstructured":"Henning L, Schellenberg D, Smith T, Henning D, Alonso P, Tanner M, Mshinda H, Beck HP, Felger I, Henning L, Schellenberg D, Smith T: A prospective study of plasmodium falciparum multiplicity of infection and morbidity in Tanzanian children. Trans R Soc Trop Med Hyg. 2004, 98: 687-694. 10.1016\/j.trstmh.2004.03.010.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2439_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3945\/ajcn.110.006700","volume":"92","author":"H Verhoef","year":"2010","unstructured":"Verhoef H: Asymptomatic malaria in the etiology of iron deficiency anemia: a malariologist\u2019s viewpoint. Am J Clin Nutr. 2010, 92: 1285-1286. 10.3945\/ajcn.110.006700.","journal-title":"Am J Clin Nutr"},{"key":"2439_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0169-4758(00)01658-6","volume":"16","author":"DA Bundy","year":"2000","unstructured":"Bundy DA, Lwin S, Osika JS, McLaughlin J, Pannenborg CO: What should schools do about malaria?. Parasitol Today. 2000, 16: 181-182. 10.1016\/S0169-4758(00)01658-6.","journal-title":"Parasitol Today"},{"key":"2439_CR11","doi-asserted-by":"publisher","first-page":"e4000","DOI":"10.1371\/journal.pone.0004000","volume":"3","author":"M Kweku","year":"2008","unstructured":"Kweku M, Liu D, Adjuik M, Binka F, Seidu M, Greenwood B, Chandramohan D: Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One. 2008, 3: e4000-10.1371\/journal.pone.0004000.","journal-title":"PLoS One"},{"key":"2439_CR12","doi-asserted-by":"publisher","first-page":"e1000408","DOI":"10.1371\/journal.pmed.1000408","volume":"8","author":"AT Konat\u00e9","year":"2011","unstructured":"Konat\u00e9 AT, Yaro JB, Ou\u00e9draogo AZ, Diarra A, Gansan\u00e9 A, Soulama I, Kangoy\u00e9 DT, Kabor\u00e9 Y, Ou\u00e9draogo E, Ou\u00e9draogo A, Tiono AB, Ou\u00e9draogo IN, Chandramohan D, Cousens S, Milligan PJ, Sirima SB, Greenwood B, Diallo DA: Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011, 8: e1000408-10.1371\/journal.pmed.1000408.","journal-title":"PLoS Med"},{"key":"2439_CR13","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0140-6736(09)61258-7","volume":"374","author":"JJ Aponte","year":"2009","unstructured":"Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M: Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet. 2009, 374: 1533-1542. 10.1016\/S0140-6736(09)61258-7.","journal-title":"Lancet"},{"key":"2439_CR14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1365-3156.2006.01657.x","volume":"11","author":"B Greenwood","year":"2006","unstructured":"Greenwood B: Review: intermittent preventive treatment\u2013a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health. 2006, 11: 983-991. 10.1111\/j.1365-3156.2006.01657.x.","journal-title":"Trop Med Int Health"},{"key":"2439_CR15","doi-asserted-by":"publisher","first-page":"e11225","DOI":"10.1371\/journal.pone.0011225","volume":"5","author":"K Bojang","year":"2010","unstructured":"Bojang K, Akor F, Bittaye O, Conway D, Bottomley C, Milligan P, Greenwood B: A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children. PLoS One. 2010, 5: e11225-10.1371\/journal.pone.0011225.","journal-title":"PLoS One"},{"key":"2439_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1586\/eri.10.36","volume":"8","author":"RD Gosling","year":"2010","unstructured":"Gosling RD, Cairns ME, Chico RM, Chandramohan D: Intermittent preventive treatment against malaria: an update. Expert Rev Anti Infect Ther. 2010, 8: 589-606. 10.1586\/eri.10.36.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2439_CR17","volume-title":"WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparummalaria control in Africa","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparummalaria control in Africa. 2010,http:\/\/www.who.int\/malaria\/news\/WHO_policy_recommendation_IPTi_032010.pdf,"},{"key":"2439_CR18","volume-title":"Malaria Control in Schools. A toolkit on effective education sector responses to malaria in Africa","author":"Partnership for Child Development, London School of Hygiene and Tropical Medicine, Kenya Medical Research Institute-Wellcome Trust Research Programme, The World Bank London School of Hygiene and Tropical Medicine","year":"2009","unstructured":"Partnership for Child Development, London School of Hygiene and Tropical Medicine, Kenya Medical Research Institute-Wellcome Trust Research Programme, The World Bank London School of Hygiene and Tropical Medicine: Malaria Control in Schools. A toolkit on effective education sector responses to malaria in Africa. 2009,http:\/\/www.schoolsandhealth.org\/Documents\/Malaria%20Toolkit%20for%20Schools%202009.pdf,"},{"key":"2439_CR19","volume-title":"Eurartesim dihydroartemisinin\/piperaquine phosphate","author":"European Medicines Agency","year":"2011","unstructured":"European Medicines Agency: Eurartesim dihydroartemisinin\/piperaquine phosphate. 2011,http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/001199\/WC500118116.pdf,"},{"key":"2439_CR20","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0140-6736(09)61629-9","volume":"374","author":"R McGready","year":"2009","unstructured":"McGready R: Intermittent preventive treatment of malaria in infancy. Lancet. 2009, 374: 1478-1480. 10.1016\/S0140-6736(09)61629-9.","journal-title":"Lancet"},{"key":"2439_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1472-8206.2003.00164.x","volume":"17","author":"J Le Bras","year":"2003","unstructured":"Le Bras J, Durand R: The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam Clin Pharmacol. 2003, 17: 147-153. 10.1046\/j.1472-8206.2003.00164.x.","journal-title":"Fundam Clin Pharmacol"},{"key":"2439_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1475-2875-9-247","volume":"9","author":"S Sridaran","year":"2010","unstructured":"Sridaran S, McClintock SK, Syphard LM, Herman KM, Barnwell JW, Udhayakumar V: Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African plasmodium falciparum parasite populations. Malar J. 2010, 9: 247-10.1186\/1475-2875-9-247.","journal-title":"Malar J"},{"key":"2439_CR23","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1086\/315520","volume":"181","author":"AM Nzila","year":"2000","unstructured":"Nzila AM, Nduati E, Mberu EK, Hopkins SC, Monks SA, Winstanley PA, Watkins WM: Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine\/sulfadoxine compared with the shorter-acting chlorproguanil\/dapsone on Kenyan plasmodium falciparum. J Infect Dis. 2000, 181: 2023-2028. 10.1086\/315520.","journal-title":"J Infect Dis"},{"key":"2439_CR24","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.trstmh.2009.06.007","volume":"103","author":"M Cairns","year":"2009","unstructured":"Cairns M, Gosling R, Gesase S, Mosha J, Greenwood B, Chandramohan D: Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants. Trans R Soc Trop Med Hyg. 2009, 103: 1199-1201. 10.1016\/j.trstmh.2009.06.007.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2439_CR25","doi-asserted-by":"publisher","first-page":"e7164","DOI":"10.1371\/journal.pone.0007164","volume":"4","author":"B Cisse","year":"2009","unstructured":"Cisse B, Cairns M, Faye E, NDiaye O, Faye B, Cames C, Cheng Y, NDiaye M, L\u00f4 AC, Simondon K, Trape JF, Faye O, NDiaye JL, Gaye O, Greenwood B, Milligan P: Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS One. 2009, 4: e7164-10.1371\/journal.pone.0007164.","journal-title":"PLoS One"},{"key":"2439_CR26","volume-title":"Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers","author":"World Health Organization","year":"2006","unstructured":"World Health Organization: Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. 2006,http:\/\/whqlibdoc.who.int\/publications\/2006\/9241547103_eng.pdf,"},{"key":"2439_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(08)61034-X","volume":"372","author":"SE Clarke","year":"2008","unstructured":"Clarke SE, Jukes MC, Njagi JK, Khasakhala L, Cundill B, Otido J, Crudder C, Estambale BB, Brooker S: Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2008, 372: 127-138. 10.1016\/S0140-6736(08)61034-X.","journal-title":"Lancet"},{"key":"2439_CR28","unstructured":"US Food and Drug Administration: Fansidar (Sulfadoxine and Pyrimethamine) tablet label.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/18557slr015_fansidar_lbl.pdf,"},{"key":"2439_CR29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.trstmh.2006.01.001","volume":"100","author":"C Karema","year":"2006","unstructured":"Karema C, Fanello CI, van Overmeir C, van Geertruyden JP, van Doren W, Ngamije D, D\u2019Alessandro U: Safety and efficacy of dihydroartemisinin\/piperaquine (Artekin) for the treatment of uncomplicated plasmodium falciparum malaria in Rwandan children. Trans R Soc Trop Med Hyg. 2006, 100: 1105-1111. 10.1016\/j.trstmh.2006.01.001.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2439_CR30","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1086\/344647","volume":"35","author":"MB Denis","year":"2002","unstructured":"Denis MB, Davis TM, Hewitt S, Incardona S, Nimol K, Fandeur T, Poravuth Y, Lim C, Socheat D: Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin Infect Dis. 2002, 35: 1469-1476. 10.1086\/344647.","journal-title":"Clin Infect Dis"},{"key":"2439_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1365-2125.2003.02004.x","volume":"57","author":"TY Hung","year":"2004","unstructured":"Hung TY, Davis TM, Ilett KF, Karunajeewa H, Hewitt S, Denis MB, Lim C, Socheat D: Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br J Clin Pharmacol. 2004, 57: 253-262.","journal-title":"Br J Clin Pharmacol"},{"key":"2439_CR32","unstructured":"US Food and Drug Administration: Albendazole tablet label.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020666s005s006lbl.pdf,"},{"key":"2439_CR33","unstructured":"US Food and Drug Administration: BILTRICIDE \u2013 praziquantel label.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/018714s012lbl.pdf,"},{"key":"2439_CR34","volume-title":"ICH Harmonised Tripartite Guideline. Clinical Safety Data Management: Definition and Standards for Expedited Reporting E2A. Current Step 4 version dated","author":"International Conference on Harmonisation (ICH)","year":"1994","unstructured":"International Conference on Harmonisation (ICH): ICH Harmonised Tripartite Guideline. Clinical Safety Data Management: Definition and Standards for Expedited Reporting E2A. Current Step 4 version dated. 1994,http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2A\/Step4\/E2A_Guideline.pdf, October ,"},{"key":"2439_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3945\/jn.109.114256","volume":"140","author":"F Rohner","year":"2010","unstructured":"Rohner F, Zimmermann MB, Amon RJ, Vounatsou P, Tschannen AB, N\u2019goran EK, Nindjin C, Cacou MC, T\u00e9-Bonl\u00e9 MD, Aka H, Sess DE, Utzinger J, Hurrell RF: In a randomized controlled trial of iron fortification, anthelmintic treatment, and intermittent preventive treatment of malaria for anemia control in Ivorian children, only anthelmintic treatment shows modest benefit. J Nutr. 2010, 140: 635-641. 10.3945\/jn.109.114256.","journal-title":"J Nutr"},{"key":"2439_CR36","doi-asserted-by":"publisher","first-page":"e13438","DOI":"10.1371\/journal.pone.0013438","volume":"5","author":"J Nankabirwa","year":"2010","unstructured":"Nankabirwa J, Cundill B, Clarke S, Kabatereine N, Rosenthal PJ, Dorsey G, Brooker S, Staedke SG: Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren. PLoS One. 2010, 5: e13438-10.1371\/journal.pone.0013438.","journal-title":"PLoS One"},{"key":"2439_CR37","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organisation","year":"2010","unstructured":"World Health Organisation: Guidelines for the treatment of malaria. 2010,http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241547925_eng.pdf, Second,","edition":"Second"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-14-311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:59:33Z","timestamp":1630609173000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-14-311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2439"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-14-311","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,24]]},"assertion":[{"value":"25 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"311"}}